The likelihood for avoidance of five clinically important outcomes in patients with COPD and type 2 inflammation was greater with dupilumab vs. placebo, according to findings from a win ratio analysis ...

Slow progress, pipeline uncertainty & lack of catalysts weigh despite strong cash. Click to read why KYMR stock is a Hold.

The Health Sciences Authority (HSA) has approved Dupixent (dupilumab) for adults as an add-on maintenance treatment for uncontrolled chronic obstructive pulmonary disease (COPD) characterized by ...

Detailed price information for Apogee Therapeutics Inc (APGE-Q) from The Globe and Mail including charting and trades.

Immunology drug Dupixent is seeing very strong, steady growth in atopic dermatitis and asthma, and approvals continue to expend to new indications (nasal polyposis) and younger patients.

Need a way to livestream the Barcelona vs. Inter Champions League game today? Read on. Below are a few ways to watch Barcelona vs. Inter Milan, including a way to get a free Barcelona vs.

Management projected significant growth opportunities across its portfolio, led by Dupixent for COPD and upcoming approvals for EYLEA HD enhancements, including retinal vein occlusion and flexible ...

Forbes contributors publish independent expert analyses and insights. Brian Mazique has covered combat sports and video games since 2011.

10, one spot below Surace. $59.99 or $89.99 for DAZN Knockout Weekend Bundle that includes the Garcia Vs. Romero, Alvarez Vs. Scull card on Saturday, May 3. The rumor mill was working overtime ...

Dupixent (dupilumab), a drug already used to treat atopic dermatitis and asthma, became the first biologic approved for chronic obstructive pulmonary disease (COPD) last fall. Most COPD treatments ...

Dupilumab shows significant efficacy in reducing itch and hives in CSU patients unresponsive to antihistamines. The CUPID A and CUPID C trials reported a two-thirds reduction in itch and urticaria ...

Barcelona vs Inter. Champions League semifinals. Football. Heritage. You can't help but cast your mind back to 2010 when thinking about this fixture. Inter's two-legged triumph over Pep Guardiola ...